-
1
-
-
18444388276
-
Late-onset sepsis in very low birth weight neonates: The experience of the NICHD Neonatal Research Network
-
DOI 10.1542/peds.110.2.285
-
Stoll, B.J. et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 110, 285-291 (2002). (Pubitemid 34833012)
-
(2002)
Pediatrics
, vol.110
, Issue.2
, pp. 285-291
-
-
Stoll, B.J.1
Hansen, N.2
Fanaroff, A.A.3
Wright, L.L.4
Carlo, W.A.5
Ehrenkranz, R.A.6
Lemons, J.A.7
Donovan, E.F.8
Stark, A.R.9
Tyson, J.E.10
Oh, W.11
Bauer, C.R.12
Korones, S.B.13
Shankaran, S.14
Laptook, A.R.15
Stevenson, D.K.16
Papile, L.-A.17
Kenneth Poole, W.18
-
2
-
-
0042338759
-
Empirical therapy for neonatal candidemia in very low birth weight infants
-
DOI 10.1542/peds.112.3.543
-
Benjamin, D.K. Jr, DeLong, E.R., Steinbach, W.J., Cotton, C.M., Walsh, T.J. & Clark, R.H. Empirical therapy for neonatal candidemia in very low birth weight infants. Pediatrics 112, 543-547 (2003). (Pubitemid 37082104)
-
(2003)
Pediatrics
, vol.112
, Issue.3
, pp. 543-547
-
-
Benjamin Jr., D.K.1
DeLong, E.R.2
Steinbach, W.J.3
Cotton, C.M.4
Walsh, T.J.5
Clark, R.H.6
-
3
-
-
3142782023
-
Risk factors for disseminated candidiasis in children with candidemia
-
DOI 10.1097/01.inf.0000128781.77600.6f
-
Zaoutis, T.E., Greves, H.M., Lautenbach, E., Bilker, W.B. & Coffin, S.E. Risk factors for disseminated candidiasis in children with candidemia. Pediatr. Infect. Dis. J. 23, 635-641 (2004). (Pubitemid 38924888)
-
(2004)
Pediatric Infectious Disease Journal
, vol.23
, Issue.7
, pp. 635-641
-
-
Zaoutis, T.E.1
Greves, H.M.2
Lautenbach, E.3
Bilker, W.B.4
Coffin, S.E.5
-
4
-
-
0042338745
-
Neonatal candidemia and end-organ damage: A critical appraisal of the literature using meta-analytic techniques
-
DOI 10.1542/peds.112.3.634
-
Benjamin, D.K. Jr, Poole, C., Steinbach, W.J., Rowen, J.L. & Walsh, T.J. Neonatal candidemia and end-organ damage: a critical appraisal of the literature using meta-analytic techniques. Pediatrics 112, 634-640 (2003). (Pubitemid 37082118)
-
(2003)
Pediatrics
, vol.112
, Issue.3
, pp. 634-640
-
-
Benjamin Jr., D.K.1
Poole, C.2
Steinbach, W.J.3
Rowen, J.L.4
Walsh, T.J.5
-
5
-
-
33644836691
-
Neonatal candidiasis among extremely low birth weight infants: Risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months
-
DOI 10.1542/peds.2004-2292
-
Benjamin, D.K. Jr et al. National Institute of Child Health and Human Development Neonatal Research Network. Neonatal candidiasis among extremely low birth weight infants: risk factors, Mortality rates, And neurodevelopmental outcomes at 18 to 22 months. Pediatrics 117, 84-92 (2006). (Pubitemid 46050523)
-
(2006)
Pediatrics
, vol.117
, Issue.1
, pp. 84-92
-
-
Benjamin Jr., D.K.1
Stoll, B.J.2
Fanaroff, A.A.3
McDonald, S.A.4
Oh, W.5
Higgins, R.D.6
Duara, S.7
Poole, K.8
Laptook, A.9
Goldberg, R.10
-
6
-
-
27744433240
-
In vitro activities of anidulafungin against more than 2,500 clinical isolates of Candida spp., including 315 isolates resistant to fluconazole
-
DOI 10.1128/JCM.43.11.5425-5427.2005
-
Pfaller, M.A., Boyken, L., Hollis, R.J., Messer, S.A., Tendolkar, S. & Diekema, D.J. In vitro activities of anidulafungin against more than 2,500 clinical isolates of Candida spp., Including 315 isolates resistant to fluconazole. J. Clin. Microbiol. 43, 5425-5427 (2005). (Pubitemid 41612308)
-
(2005)
Journal of Clinical Microbiology
, vol.43
, Issue.11
, pp. 5425-5427
-
-
Pfaller, M.A.1
Boyken, L.2
Hollis, R.J.3
Messer, S.A.4
Tendolkar, S.5
Diekema, D.J.6
-
7
-
-
0032824392
-
Antifungal activity of LY303366, a novel echinocandin B, in experimental disseminated candidiasis in rabbits
-
Petraitiene, R. et al. antifungal activity of Ly303366, A novel echinocandin B, In experimental disseminated candidiasis in rabbits. Antimicrob. Agents Chemother. 43, 2148-2155 (1999). (Pubitemid 29421192)
-
(1999)
Antimicrobial Agents and Chemotherapy
, vol.43
, Issue.9
, pp. 2148-2155
-
-
Petraitiene, R.1
Petraitis, V.2
Groll, A.H.3
Candelario, M.4
Sein, T.5
Bell, A.6
Lyman, C.A.7
McMillian, C.L.8
Bacher, J.9
Walsh, T.J.10
-
8
-
-
0035139521
-
Dosage-dependent antifungal efficacy of V-echinocandin (LY303366) against experimental fluconazole-resistant oropharyngeal and esophageal candidiasis
-
DOI 10.1128/AAC.45.2.471-479.2001
-
Petraitis, V. et al. Dosage-dependent antifungal efficacy of V-echinocandin (Ly303366) against experimental fluconazole-resistant oropharyngeal and esophageal candidiasis. Antimicrob. Agents Chemother. 45, 471-479 (2001). (Pubitemid 32105283)
-
(2001)
Antimicrobial Agents and Chemotherapy
, vol.45
, Issue.2
, pp. 471-479
-
-
Petraitis, V.1
Petraitiene, R.2
Groll, A.H.3
Sein, T.4
Schaufele, R.L.5
Lyman, C.A.6
Francesconi, A.7
Bacher, J.8
Piscitelli, S.C.9
Walsh, T.J.10
-
9
-
-
2442695447
-
Population pharmacokinetic analysis of anidulafungin, an echinocandin antifungal
-
DOI 10.1177/0091270004265644
-
Dowell, J.A., Knebel, W., Ludden, T., Stogniew, M., Krause, D. & Henkel, T. Population pharmacokinetic analysis of anidulafungin, An echinocandin antifungal. J. Clin. Pharmacol. 44, 590-598 (2004). (Pubitemid 38668021)
-
(2004)
Journal of Clinical Pharmacology
, vol.44
, Issue.6
, pp. 590-598
-
-
Dowell, J.A.1
Knebel, W.2
Ludden, T.3
Stogniew, M.4
Krause, D.5
Henkel, T.6
-
10
-
-
62949151478
-
In vitro and in vivo studies to characterize the clearance mechanism and potential cytochrome P450 interactions of anidulafungin
-
Damle, B.D., Dowell, J.A., Walsky, R.L., Weber, G.L., Stogniew, M. & Inskeep, P.B. In vitro and in vivo studies to characterize the clearance mechanism and potential cytochrome P450 interactions of anidulafungin. Antimicrob. Agents Chemother. 53, 1149-1156 (2009).
-
(2009)
Antimicrob. Agents Chemother.
, vol.53
, pp. 1149-1156
-
-
Damle, B.D.1
Dowell, J.A.2
Walsky, R.L.3
Weber, G.L.4
Stogniew, M.5
Inskeep, P.B.6
-
11
-
-
33947500054
-
Anidulafungin does not require dosage adjustment in subjects with varying degrees of hepatic or renal impairment
-
DOI 10.1177/0091270006297227
-
Dowell, J.A., Stogniew, M., Krause, D. & Damle, B. anidulafungin does not require dosage adjustment in subjects with varying degrees of hepatic or renal impairment. J. Clin. Pharmacol. 47, 461-470 (2007). (Pubitemid 46465954)
-
(2007)
Journal of Clinical Pharmacology
, vol.47
, Issue.4
, pp. 461-470
-
-
Dowell, J.A.1
Stogniew, M.2
Krause, D.3
Damle, B.4
-
12
-
-
31944441962
-
Safety and pharmacokinetics of intravenous anidulafungin in children with neutropenia at high risk for invasive fungal infections
-
DOI 10.1128/AAC.50.2.632-638.2006
-
Benjamin, D.K. Jr et al. Safety and pharmacokinetics of intravenous anidulafungin in children with neutropenia at high risk for invasive fungal infections. Antimicrob. Agents Chemother. 50, 632-638 (2006). (Pubitemid 43190976)
-
(2006)
Antimicrobial Agents and Chemotherapy
, vol.50
, Issue.2
, pp. 632-638
-
-
Benjamin Jr., D.K.1
Driscoll, T.2
Seibel, N.L.3
Gonzalez, C.E.4
Roden, M.M.5
Kilaru, R.6
Clark, K.7
Dowell, J.A.8
Schranz, J.9
Walsh, T.J.10
-
13
-
-
39349084676
-
The pharmacokinetics and pharmacodynamics of micafungin in experimental hematogenous Candida meningoencephalitis: Implications for echinocandin therapy in neonates
-
DOI 10.1086/524063
-
Hope, W.W. et al. The pharmacokinetics and pharmacodynamics of micafungin in experimental hematogenous Candida meningoencephalitis: implications for echinocandin therapy in neonates. J. Infect. Dis. 197, 163-171 (2008). (Pubitemid 351263481)
-
(2008)
Journal of Infectious Diseases
, vol.197
, Issue.1
, pp. 163-171
-
-
Hope, W.W.1
Mickiene, D.2
Petraitis, V.3
Petraitiene, R.4
Kelaher, A.M.5
Hughes, J.E.6
Cotton, M.P.7
Bacher, J.8
Keirns, J.J.9
Buell, D.10
Heresi, G.11
Benjamin Jr., D.K.12
Groll, A.H.13
Drusano, G.L.14
Walsh, T.J.15
-
14
-
-
16644371770
-
Caspofungin therapy of neonates with invasive candidiasis
-
DOI 10.1097/01.inf.0000145408.51526.0a
-
Odio, C.M. et al. Caspofungin therapy of neonates with invasive candidiasis. Pediatr. Infect. Dis. J. 23, 1093-1097 (2004). (Pubitemid 40812754)
-
(2004)
Pediatric Infectious Disease Journal
, vol.23
, Issue.12
, pp. 1093-1097
-
-
Odio, C.M.1
Araya, R.2
Pinto, L.E.3
Castro, C.E.4
Vasquez, S.5
Alfaro, B.6
Saenz, A.7
Herrera, M.L.8
Walsh, T.J.9
-
15
-
-
0029965509
-
Pharmacokinetics of vancomycin in critically ill infants undergoing extracorporeal membrane oxygenation
-
Amaker, R.D., DiPiro, J.T. & Bhatia, J. Pharmacokinetics of vancomycin in critically ill infants undergoing extracorporeal membrane oxygenation. Antimicrob. Agents Chemother. 40, 1139-1142 (1996). (Pubitemid 26136023)
-
(1996)
Antimicrobial Agents and Chemotherapy
, vol.40
, Issue.5
, pp. 1139-1142
-
-
Amaker, R.D.1
Dipiro, J.T.2
Bhatia, J.3
-
16
-
-
0026568933
-
Gentamicin pharmacokinetics in term neonates receiving extracorporeal membrane oxygenation
-
Bhatt-Mehta, V., Johnson, C.E. & Schumacher, R.E. Gentamicin pharmacokinetics in term neonates receiving extracorporeal membrane oxygenation. Pharmacotherapy 12, 28-32 (1992).
-
(1992)
Pharmacotherapy
, vol.12
, pp. 28-32
-
-
Bhatt-Mehta, V.1
Johnson, C.E.2
Schumacher, R.E.3
-
17
-
-
34249691835
-
Potential drug sequestration during extracorporeal membrane oxygenation: Results from an ex vivo experiment
-
DOI 10.1007/s00134-007-0606-2
-
Mehta, N.M., Halwick, D.R., Dodson, B.L., Thompson, J.E. & Arnold, J.H. Potential drug sequestration during extracorporeal membrane oxygenation: results from an ex vivo experiment. Intensive Care Med. 33, 1018-1024 (2007). (Pubitemid 46835404)
-
(2007)
Intensive Care Medicine
, vol.33
, Issue.6
, pp. 1018-1024
-
-
Mehta, N.M.1
Halwick, D.R.2
Dodson, B.L.3
Thompson, J.E.4
Arnold, J.H.5
-
18
-
-
34250341787
-
Anidulafungin versus fluconazole for invasive candidiasis
-
Reboli, A.C. et al. anidulafungin Study Group. anidulafungin versus fluconazole for invasive candidiasis. N. Engl. J. Med. 356, 2472-2482 (2007). (Pubitemid 46919773)
-
(2007)
New England Journal of Medicine
, vol.356
, Issue.24
, pp. 2472-2482
-
-
Reboli, A.C.1
Rotstein, C.2
Pappas, P.G.3
Chapman, S.W.4
Kett, D.H.5
Kumar, D.6
Betts, R.7
Wible, M.8
Goldstein, B.P.9
Schranz, J.10
Krause, D.S.11
Walsh, T.J.12
|